 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2024 |
$1.24 |
$1.28 |
$1.24 |
$1.27 |
52.80K | | 04/12/2024 |
$1.25 |
$1.28 |
$1.17 |
$1.20 |
338.90K | | 04/15/2024 |
$1.19 |
$1.20 |
$1.12 |
$1.13 |
174.80K | | 04/16/2024 |
$1.15 |
$1.15 |
$1.08 |
$1.15 |
101.70K | | 04/17/2024 |
$1.14 |
$1.15 |
$1.11 |
$1.11 |
74.50K |
|
|
| Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer.. Co.'s proprietary Boltbody™ ISAC (immune-stimulating antibody conjugate) platform technology combines tumor-targeting antibodies with immune-stimulating linker payloads to create productive anti-tumor immune responses. Co.'s lead product candidate, BDC-1001, is in clinical development for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-expressing solid tumors, including gastroesophageal cancer. Co.'s second program, BDC-3042, is an agonist antibody targeting Dectin-2, an innate immune receptor found on the surface of macrophages. | |
|
Bolt Biotherapeutics (BOLT) has the following price history information. Looking back at BOLT historical stock prices for the last five trading days, on April 11, 2024, BOLT opened at $1.24, traded as high as $1.28 and as low as $1.24, and closed at $1.27. Trading volume was a total of 52.80K shares. On April 12, 2024, BOLT opened at $1.25, traded as high as $1.28 and as low as $1.17, and closed at $1.20. Trading volume was a total of 338.90K shares. On April 15, 2024, BOLT opened at $1.19, traded as high as $1.20 and as low as $1.12, and closed at $1.13. Trading volume was a total of 174.80K shares. On April 16, 2024, BOLT opened at $1.15, traded as high as $1.15 and as low as $1.08, and closed at $1.15. Trading volume was a total of 101.70K shares. On April 17, 2024, BOLT opened at $1.14, traded as high as $1.15 and as low as $1.11, and closed at $1.11. Trading volume was a total of 74.50K shares.
BOLT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bolt Biotherapeutics shares, starting with a $10,000 purchase of BOLT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/05/2021 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$32.15 |
|
| End price/share: |
$1.11 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.55% |
|
| Average Annual Total Return: |
-65.14% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$345.11 |
|
| Years: |
3.19 |
|
|
|
| Date |
Close |
| 04/11/2024 | $1.27 | | 04/12/2024 | $1.20 | | 04/15/2024 | $1.13 | | 04/16/2024 | $1.15 | | 04/17/2024 | $1.11 |
|
|
Free BOLT Email Alerts:
